Michael A. Rogawski
Michael A. Rogawski
Professor of Neurology and Pharmacology, University of California,Davis
Verified email at ucdavis.edu - Homepage
Title
Cited by
Cited by
Year
The neurobiology of antiepileptic drugs
MA Rogawski, W Löscher
Nature Reviews Neuroscience 5 (7), 553-564, 2004
12392004
D-serine is an endogenous ligand for the glycine site of the N-methyl-D-aspartate receptor
JP Mothet, AT Parent, H Wolosker, RO Brady, DJ Linden, CD Ferris, ...
Proceedings of the National Academy of Sciences 97 (9), 4926-4931, 2000
11942000
Antiepileptic drugs: pharmacologiacal mechanisms and clinical efficacy with consideration of promising developmental stage compounds.
MA Rogawsky
Pharmacol. Rev. 42, 223-286, 1990
8951990
Glia and epilepsy: excitability and inflammation
O Devinsky, A Vezzani, S Najjar, NC De Lanerolle, MA Rogawski
Trends in neurosciences 36 (3), 174-184, 2013
5762013
Molecular targets for antiepileptic drug development
BS Meldrum, MA Rogawski
Neurotherapeutics 4 (1), 18-61, 2007
5192007
The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions
MA Rogawski, W Löscher
Nature medicine 10 (7), 685-692, 2004
5102004
Neuroprotective and disease-modifying effects of the ketogenic diet
M Gasior, MA Rogawski, AL Hartman
Behavioural pharmacology 17 (5-6), 431, 2006
5092006
The neuropharmacological basis for the use of memantine in the treatment of Alzheimer's disease
MA Rogawski, GL Wenk
CNS drug reviews 9 (3), 275-308, 2003
4522003
Colchicine myopathy and neuropathy
RW Kuncl, G Duncan, D Watson, K Alderson, MA Rogawski, M Peper
New England Journal of Medicine 316 (25), 1562-1568, 1987
4251987
GYKI 52466, a 2, 3-benzodiazepine, is a highly selective, noncompetitive antagonist of AMPA/kainate receptor responses
SD Donevan, MA Rogawski
Neuron 10 (1), 51-59, 1993
4211993
Adjunctive perampanel for refractory partial-onset seizures: randomized phase III study 304
JA French, GL Krauss, V Biton, D Squillacote, H Yang, A Laurenza, ...
Neurology 79 (6), 589-596, 2012
4192012
Anticonvulsant activity of neurosteroids: correlation with gamma-aminobutyric acid-evoked chloride current potentiation.
TG Kokate, BE Svensson, MA Rogawski
Journal of Pharmacology and Experimental Therapeutics 270 (3), 1223-1229, 1994
4061994
The A-current: how ubiquitous a feature of excitable cells is it?
MA Rogawski
Trends in Neurosciences 8, 214-219, 1985
4021985
Therapeutic potential of excitatory amino acid antagonists: channel blockers and 2, 3-benzodiazepines
MA Rogawski
Trends in pharmacological sciences 14 (9), 325-331, 1993
3931993
Diverse mechanisms of antiepileptic drugs in the development pipeline
MA Rogawski
Epilepsy research 69 (3), 273-294, 2006
3822006
Revisiting AMPA receptors as an antiepileptic drug target: revisiting AMPA receptors as an antiepileptic drug target
MA Rogawski
Epilepsy currents 11 (2), 56-63, 2011
3542011
The neuropharmacology of the ketogenic diet
AL Hartman, M Gasior, EPG Vining, MA Rogawski
Pediatric neurology 36 (5), 281-292, 2007
3182007
Stress-induced deoxycorticosterone-derived neurosteroids modulate GABAA receptor function and seizure susceptibility
DS Reddy, MA Rogawski
Journal of Neuroscience 22 (9), 3795-3805, 2002
2902002
“Jasper’s Basic Mechanisms of the Epilepsies” Workshop
JL Noebels, M Avoli, M Rogawski, R Olsen, AV Delgado‐Escueta
Epilepsia 51, 1-5, 2010
274*2010
Intracellular polyamines mediate inward rectification of Ca (2+)-permeable alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors
SD Donevan, MA Rogawski
Proceedings of the National Academy of Sciences 92 (20), 9298-9302, 1995
2621995
The system can't perform the operation now. Try again later.
Articles 1–20